U.S. Entertainment Stock News

If you are wondering whether BioCryst Pharmaceuticals, at a last close of US$8.90, still offers value, it helps to step back and look at the full valuation picture rather than just the recent share price. The stock is up 18.7% year to date, although it has seen a 2.8% decline over the last week and a 7.2% decline over the last month, and the 1 year return sits at a 10.3% decline. Recent news coverage has focused on BioCryst Pharmaceuticals' pipeline progress and its positioning within the...

The US House previously passed a farm bill that includes a very large US$187 billion reduction to SNAP, alongside updates to crop insurance and commodity price supports that could reshape food assistance and agricultural markets for companies like Conagra Brands. At the same time, Conagra’s new Citizenship Report and updated bylaws highlight its focus on sustainability and shareholder engagement just as major policy changes introduce fresh demand uncertainty. We’ll now examine how this very...

Nextpower (NasdaqGS:NXT) has appointed Lindsey Wiedmann as its new Chief Legal and Compliance Officer. Wiedmann steps in following the retirement of Bruce Ledesma from the role. She previously held senior legal and compliance responsibilities at Maxeon Solar Technologies, bringing sector specific experience. For readers tracking NasdaqGS:NXT, this shift in leadership comes at a time when solar and broader clean energy businesses are closely watched for how they handle regulation, policy...

Event context and recent share performance Andersen Group (ANDG) recently drew investor interest after a session that left the stock at $35.98, with single day and past week returns of 2.27% and 1.70% respectively. Over the past month and past 3 months, Andersen Group has delivered returns of 25.58% and 67.97%, while year to date the stock shows a 47.58% total return. See our latest analysis for Andersen Group. For context, Andersen Group's recent 1 month share price return of 25.58% and 3...

Beam Therapeutics earnings and clinical updates reshape investor focus Beam Therapeutics (BEAM) stock has been in focus after first quarter results showed a net loss of US$94.32 million and a basic loss per share of US$0.91, alongside revenue that exceeded consensus estimates. See our latest analysis for Beam Therapeutics. The latest earnings beat on revenue and a string of encouraging clinical updates have come alongside strong recent momentum, with a 28.50% 1 month share price return and...

StandardAero (SARO) has wrapped up FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$0.24, supported by trailing 12 month revenue of US$6.1b and EPS of US$0.84 that sit against a very large reported earnings expansion over the past year. The company has seen quarterly revenue move from US$1.41b in Q4 2024 to US$1.60b in Q4 2025, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.24 over the same period, with trailing net profit margins now framed against a...

IDEX Corporation previously announced that its Board approved a regular quarterly cash dividend of US$0.73 per share, payable June 5, 2026 to shareholders of record on May 22, 2026, while also reporting first‑quarter 2026 sales of US$886.9 million and net income of US$120 million. This combination of higher quarterly earnings and the company’s 126th consecutive regular dividend, alongside continued share repurchases, underscores a consistent focus on shareholder returns. We’ll now explore...

In early May 2026, UL Solutions Inc. reported first-quarter sales of US$758 million and net income of US$92 million, while also launching new UL Type Examination Certification services for hydrogen fueling station valves and dispenser hoses aligned with ISO 19880-3 and ISO 19880-5 standards. By expanding into hydrogen infrastructure safety testing alongside existing global facilities, UL Solutions is deepening its role as an independent gatekeeper for complex, safety-critical technologies...

Dropbox (DBX) has wrapped up FY 2025 with fourth quarter revenue of US$636.2 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$2.5 billion and EPS of US$1.89 that frame the full year picture. Over the past six quarters in the data provided, quarterly revenue has moved between US$624.7 million and US$643.6 million, while basic EPS has ranged from US$0.34 to US$0.52, giving you a clear view of how the top line and per share earnings have tracked together. For...

Upstart Holdings (UPST) has been back in focus after first quarter 2026 results showed a wider net loss alongside reaffirmed full year revenue guidance, while multiple securities class actions continue to hang over its AI lending model. See our latest analysis for Upstart Holdings. The recent Q1 report, which combined 44% year over year revenue growth with a wider net loss and ongoing class action headlines, has kept pressure on sentiment. This is reflected in a 36.74% year to date share...

If you are wondering whether Prestige Consumer Healthcare is attractively priced or just a value trap, the stock's recent performance and fundamentals give you plenty to weigh up. The share price recently closed at US$54.59, with returns of a 3.1% decline over 7 days, a 1.9% decline over 30 days, a 10.8% decline year to date, and a 37.3% decline over the last year, while the 3 year and 5 year returns stand at a 6.4% decline and 12.3% respectively. Recent coverage has focused on Prestige...

Earnings update and what it means for Kite Realty Group Trust (KRG) Kite Realty Group Trust (KRG) has drawn fresh attention after reporting first quarter 2026 results that showed lower sales, revenue, and net income than a year earlier, alongside new full year earnings guidance. See our latest analysis for Kite Realty Group Trust. Despite softer first quarter earnings, investors have recently bid Kite Realty Group Trust higher, with a 7.4% 90 day share price return and 12.2% year to date...

Recent performance snapshot ON Semiconductor (ON) has drawn fresh attention after a strong run in its stock price over the month and past 3 months, while also posting annual revenue of US$6.06b and net income of US$573.7m. See our latest analysis for ON Semiconductor. That recent surge in momentum is set against a mixed backdrop, with the 1 day share price return of 4.90% and 7 day share price return of 0.23% sitting alongside a 30 day share price return of 57.68% and 1 year total shareholder...

nVent Electric (NVT) is back in focus after first quarter earnings comfortably beat analyst expectations, prompting the company to lift its guidance and drawing attention to AI data center driven demand and a growing backlog. See our latest analysis for nVent Electric. The share price has surged recently, with a 7 day share price return of 16.68% and a 30 day share price return of 40.20%. The 1 year total shareholder return is very large, suggesting momentum has been building around the AI...

Recent performance snapshot United Therapeutics (UTHR) has drawn attention after a strong past year, with a 1-year total return of 84.8% and a 3-month return of 17.3%. This has prompted closer scrutiny of its current valuation and fundamentals. See our latest analysis for United Therapeutics. The recent 1-day share price return of a 4.6% decline sits against a 90-day share price return of 17.3% and a 1-year total shareholder return of 84.8%. This suggests momentum has been building over a...

Global-E Online (GLBE) is back in focus after quarterly results beat Wall Street expectations, with gross merchandise value up 31% and management lifting full-year 2024 revenue and adjusted EBITDA guidance. See our latest analysis for Global-E Online. The strong earnings beat has been followed by a 4.52% 1 day share price return to US$32.63. However, the year to date share price return of 13.81% and 1 year total shareholder return of 13.06% suggest recent momentum contrasts with weaker longer...

Recent price performance puts Fannie Mae in focus Federal National Mortgage Association (FNMA) has caught investor attention after a one-month return of about 26%, contrasting with a year-to-date decline of roughly 27% and a modestly positive performance over the past three months. See our latest analysis for Federal National Mortgage Association. Recent share price momentum looks mixed, with the 30 day share price return of about 26% contrasting with a weaker year to date share price...

Tyler Technologies (TYL) is back in focus after its first quarter 2026 earnings update, which paired higher recurring revenues and a Justice portfolio acquisition with fresh full year guidance and renewed investor attention. See our latest analysis for Tyler Technologies. Despite the Q1 earnings update and ongoing buybacks in early 2026, Tyler Technologies’ recent share price return has been weak. A 1 day share price return of 3.25% contrasts with a year to date share price return of 24.03%...

If you are wondering whether Advance Auto Parts stock still offers value at current levels, it helps to line up its recent returns with what the fundamentals and valuation checks are actually saying. The stock last closed at US$57.23, with returns of 8.7% over the past 30 days, 47.2% year to date and 85.9% over the past year, while the 3 year and 5 year returns of negative 51.1% and negative 68.4% show a very different experience for longer term holders. Recent news around Advance Auto Parts...

In recent weeks, Bitmine Immersion Technologies, Inc. has withdrawn an US$11.03 million shelf registration, continued large Ethereum purchases, expanded its share repurchase authorization to US$4.00 billion, and uplisted its stock to the New York Stock Exchange. An unusual aspect of this story is Bitmine’s attempt to build an institutional equity wrapper around a crypto treasury holding more than 5.18 million ETH, including over 4.36 million staked through its MAVAN platform. Against this...

Immatics stock in focus Immatics (NasdaqCM:IMTX) is drawing attention after recent share price moves, with the stock last closing at US$11.14 and showing positive total returns over the past year and the past 3 months. See our latest analysis for Immatics. Recent moves fit a bigger pattern, with a 30 day share price return of 8.68% and a 90 day share price return of 15.68%, alongside a very large 1 year total shareholder return of 156.68%. These figures point to building momentum. If you are...

Earlier this week, Chemours reported first-quarter 2026 results showing sales of US$1,381 million and a net loss of US$29 million, while also filing a US$178.13 million ESOP-related shelf registration and affirming a quarterly dividend of US$0.0875 per share. Beneath the headline loss, management highlighted stronger-than-expected segment performance, debt refinancing, and guidance for sequential sales and adjusted EBITDA improvement in the second quarter of 2026. We’ll now explore how...

Investors may be wondering whether CONMED at around US$38.10 is starting to offer value, or if the stock’s long slide still reflects unresolved risks. The share price recently closed at US$38.10, with a 3.9% move over 7 days and 10.3% over 30 days, against a year to date return of a 6.0% decline and a 1 year return of a 33.5% decline that sits on top of a 68.0% decline over 3 years and a 71.8% decline over 5 years. Those long term returns have sharpened focus on how investors are assessing...

Coca-Cola Consolidated reported first-quarter 2026 results with net sales of US$1,846.67 million and net income of US$111.56 million, alongside plans for a US$35 million expansion of its Indianapolis glass bottling facility announced earlier this month. The Indianapolis plant investment will make it one of only three facilities in the U.S. Coca-Cola system capable of bottling beverages in glass, while margin pressure and weaker adjusted net income have become a key focus for investors. We’ll...